Home

Seres Therapeutics, Inc. - Common Stock (MCRB)

0.3999
-0.0621 (-13.44%)
NASDAQ · Last Trade: Apr 16th, 8:38 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · April 15, 2025
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · April 14, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · April 14, 2025
Earnings Scheduled For November 13, 2024benzinga.com
Via Benzinga · November 13, 2024
What's Next: Seres Therapeutics's Earnings Previewbenzinga.com
Via Benzinga · November 12, 2024
Seres Therapeutics's Earnings: A Previewbenzinga.com
Via Benzinga · March 4, 2024
Earnings Scheduled For March 13, 2025benzinga.com
Via Benzinga · March 13, 2025
What's going on in today's after hours sessionchartmill.com
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · March 12, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · March 12, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 16, 2025
This Verizon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursdaybenzinga.com
Via Benzinga · October 24, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · September 26, 2024
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q2 2024investorplace.com
MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · June 10, 2024
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · June 7, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · May 9, 2024
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Via Benzinga · June 7, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · May 8, 2024
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q1 2024investorplace.com
MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 8, 2024
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 8, 2024
Nasdaq Down Over 50 Points; Uber Posts Q1 Lossbenzinga.com
Via Benzinga · May 8, 2024
Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · March 6, 2024
Gold Price Alert: Gold Spot Prices Just Hit a Record High Todayinvestorplace.com
Investors in gold are excited on Tuesday as the spot price of the precious metal hit a recent high of $2,113.28 per ounce during a rally.
Via InvestorPlace · March 5, 2024
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q4 2023investorplace.com
MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 5, 2024
Earnings Scheduled For March 5, 2024benzinga.com
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via Benzinga · March 5, 2024